1Mellen Center for Multiple Sclerosis, Neurological Institute, Cleveland Clinic, Cleveland
2Center for Neuroinflammation and Experimental Therapeutics, Department of Neurology, University of Pennsylvania, Philadelphia
3Division of Neurology, University of British Columbia, Vancouver, Canada
4Department of Neurology, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid
5Departamento de Medicina, Facultad de Medicina, Universidad Complutense de Madrid, Madrid
6Queen Mary University of London, Blizard Institute, Faculty of Medicine and Dentistry, London
7University of Lille, INSERM Unité 1172 Lille Neuroscience and Cognition, Centre Hospitalier Universitaire de Lille, Fédération Hospitalo-Universitaire PRECISE, Lille, France
8Sanofi, Cambridge, MA
9Sanofi, Bridgewater, NJ
10Translational Neuroradiology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD
Dr. Fox can be contacted at [email protected] or at the Mellen Center for Multiple Sclerosis, Neurological Institute, Cleveland Clinic, 9500 Euclid Ave., JJ-5N, Cleveland, OH 44195.
* A full list of the HERCULES Trial Group members is provided in the Supplementary Appendix, available at NEJM.org.
